Sobetirome: The past, present and questions about the future

Medicine & Life Sciences

• GC 1 compound 75%
• 3-((3,5-dibromo-4-(4-hydroxy-3-(1-methylethyl)phenoxy)phenyl)amino)-3-oxopropanoic acid 12%
• Liver 9%
• Cholesterol 9%
• Orphaned Children 8%
• Thyroid Hormone Receptors 8%
• Clinical Trials, Phase I 7%
• Dyslipidemias 5%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 5%
• Fear 5%
• Cartilage 5%
• Myocardium 5%
• Weight Loss 5%
• Cardiovascular Diseases 4%
• Dogs 4%
• Clinical Trials 3%
• Heart 3%
• Bone and Bones 3%
• Mortality 3%
• Animals 3%
• Therapeutics 3%

Chemistry

• Sobetirome 100%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 8%
• Thyroid Hormone 8%
• Cholesterol 5%
• Weight 3%
• Application 1%